Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In preclinical investigations, ischemic preconditioning (IPC) protects kidneys from ischemia/reperfusion injury. The direct effects of IPC on glomerular endothelial cells have not been studied in detail. Most investigations of IPC have focused on healthy cells and animals, and it remains unknown whether IPC is renoprotective in the setting of medical comorbidities such as diabetes. In this study, we determined the preventive potential of IPC in healthy glomerular endothelial cell monolayers, and compared these results to monolayers cultured under hyperglycemic conditions. We exposed glomerular endothelial monolayers to 1 h of IPC 24 h prior to oxygen–glucose deprivation (OGD), an in vitro model of ischemia/reperfusion injury. Glomerular endothelial monolayer integrity was assessed by measuring transendothelial electrical resistance, albumin flux, and cell survival. We found that IPC protected healthy but not hyperglycemic glomerular endothelial monolayers from ischemia/ reperfusion injury. Furthermore, not only was the protective effect of IPC lost in the setting of hyperglycemia, but IPC was actually deleterious to the integrity of hyperglycemic glomerular endothelial cell monolayers.

Original languageEnglish (US)
Article numbere12346
JournalPhysiological Reports
Volume3
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Ischemic Preconditioning
Hyperglycemia
Endothelial Cells
Reperfusion Injury
In Vitro Techniques
Electric Impedance
Comorbidity
Albumins
Cell Survival
Kidney

Keywords

  • Glomerular endothelial cells
  • Hyperglycemia
  • Ischemic preconditioning
  • Renal ischemia–reperfusion injury

ASJC Scopus subject areas

  • Physiology (medical)
  • Physiology

Cite this

@article{1d5d020f23b744a2985b56f024483007,
title = "Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro",
abstract = "In preclinical investigations, ischemic preconditioning (IPC) protects kidneys from ischemia/reperfusion injury. The direct effects of IPC on glomerular endothelial cells have not been studied in detail. Most investigations of IPC have focused on healthy cells and animals, and it remains unknown whether IPC is renoprotective in the setting of medical comorbidities such as diabetes. In this study, we determined the preventive potential of IPC in healthy glomerular endothelial cell monolayers, and compared these results to monolayers cultured under hyperglycemic conditions. We exposed glomerular endothelial monolayers to 1 h of IPC 24 h prior to oxygen–glucose deprivation (OGD), an in vitro model of ischemia/reperfusion injury. Glomerular endothelial monolayer integrity was assessed by measuring transendothelial electrical resistance, albumin flux, and cell survival. We found that IPC protected healthy but not hyperglycemic glomerular endothelial monolayers from ischemia/ reperfusion injury. Furthermore, not only was the protective effect of IPC lost in the setting of hyperglycemia, but IPC was actually deleterious to the integrity of hyperglycemic glomerular endothelial cell monolayers.",
keywords = "Glomerular endothelial cells, Hyperglycemia, Ischemic preconditioning, Renal ischemia–reperfusion injury",
author = "Schenning, {Katie J.} and Sharon Anderson and Nabil Alkayed and Michael Hutchens",
year = "2015",
doi = "10.14814/phy2.12346",
language = "English (US)",
volume = "3",
journal = "Physiological Reports",
issn = "2051-817X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro

AU - Schenning, Katie J.

AU - Anderson, Sharon

AU - Alkayed, Nabil

AU - Hutchens, Michael

PY - 2015

Y1 - 2015

N2 - In preclinical investigations, ischemic preconditioning (IPC) protects kidneys from ischemia/reperfusion injury. The direct effects of IPC on glomerular endothelial cells have not been studied in detail. Most investigations of IPC have focused on healthy cells and animals, and it remains unknown whether IPC is renoprotective in the setting of medical comorbidities such as diabetes. In this study, we determined the preventive potential of IPC in healthy glomerular endothelial cell monolayers, and compared these results to monolayers cultured under hyperglycemic conditions. We exposed glomerular endothelial monolayers to 1 h of IPC 24 h prior to oxygen–glucose deprivation (OGD), an in vitro model of ischemia/reperfusion injury. Glomerular endothelial monolayer integrity was assessed by measuring transendothelial electrical resistance, albumin flux, and cell survival. We found that IPC protected healthy but not hyperglycemic glomerular endothelial monolayers from ischemia/ reperfusion injury. Furthermore, not only was the protective effect of IPC lost in the setting of hyperglycemia, but IPC was actually deleterious to the integrity of hyperglycemic glomerular endothelial cell monolayers.

AB - In preclinical investigations, ischemic preconditioning (IPC) protects kidneys from ischemia/reperfusion injury. The direct effects of IPC on glomerular endothelial cells have not been studied in detail. Most investigations of IPC have focused on healthy cells and animals, and it remains unknown whether IPC is renoprotective in the setting of medical comorbidities such as diabetes. In this study, we determined the preventive potential of IPC in healthy glomerular endothelial cell monolayers, and compared these results to monolayers cultured under hyperglycemic conditions. We exposed glomerular endothelial monolayers to 1 h of IPC 24 h prior to oxygen–glucose deprivation (OGD), an in vitro model of ischemia/reperfusion injury. Glomerular endothelial monolayer integrity was assessed by measuring transendothelial electrical resistance, albumin flux, and cell survival. We found that IPC protected healthy but not hyperglycemic glomerular endothelial monolayers from ischemia/ reperfusion injury. Furthermore, not only was the protective effect of IPC lost in the setting of hyperglycemia, but IPC was actually deleterious to the integrity of hyperglycemic glomerular endothelial cell monolayers.

KW - Glomerular endothelial cells

KW - Hyperglycemia

KW - Ischemic preconditioning

KW - Renal ischemia–reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=85006096963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006096963&partnerID=8YFLogxK

U2 - 10.14814/phy2.12346

DO - 10.14814/phy2.12346

M3 - Article

VL - 3

JO - Physiological Reports

JF - Physiological Reports

SN - 2051-817X

IS - 3

M1 - e12346

ER -